Congratulations to Dr. Will Lockwood for receiving a BC Lung Association grant for “Defining mechanisms of lineage transformation in lung adenocarcinoma to combat therapy resistance".
Researchers at the University of British Columbia’s faculty of medicine and BC Cancer Research Institute have uncovered a weakness in a key enzyme that solid tumour cancer cells rely on to adapt and survive when oxygen levels are low.
The findings, published today in Science Advances, will help researchers develop new treatment strategies to limit the progression of solid cancer tumours, which represent the majority of tumour types that arise in the body.
A new combination treatment targeting “cancer stem cells” may overcome drug resistance in blood cancers
Building on a BC Cancer discovery from decades past, a new combination treatment has shown promise to overcome drug resistance and relapse in people with chronic myeloid leukemia.
Building off the discovery of an enzyme called integrin-linked kinase (ILK) made by BC Cancer distinguished scientist Dr. Shoukat Dedhar 24 years ago, BC Cancer’s Drs. Xiaoyan Jiang and Shoukat Dedhar have made a significant advancement in understanding the role of this enzyme in blood cancers.
Dr. Haishan Zeng receives CIHR project grant of $711,451 for “Multiphoton Photothermolysis Based Laser Therapy for Precision Treatment of Neovascular Eye Diseases”
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.